Showing 1 - 20 results of 26 for search '"human monoclonal antibodies"', query time: 0.07s Refine Results
  1. 1
  2. 2

    Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge. by Bang Li, Xiang-Rong Qin, Jia-Chen Qu, Guan-du Wu, Wen-Kang Zhang, Ze-Zheng Jiang, Pan-Pan Liu, Ze-Min Li, Tian-Mei Yu, Chuan-Min Zhou, Yong-Jun Jiao, Xue-Jie Yu

    Published 2025-01-01
    “…In this study, 4 human monoclonal antibodies (hmAbs) derived from convalescent SFTS patients' lymphocytes based on human single-chain variable fragment antibody libraries were tested for their neutralizing activities in cells and their treatment effect in animals individually and in pair combinations. …”
    Get full text
    Article
  3. 3
  4. 4

    Role of Monoclonal Antibodies in the Treatment of Asthma by Paul M O’Byrne

    Published 2013-01-01
    “…New treatment approaches developed to manage some of the phenotypes of severe refractory asthma have included humanized monoclonal antibodies (hMabs).…”
    Get full text
    Article
  5. 5

    Dupilumab for treatment of primary cutaneous amyloidosis in adults: two case reports and literature review by Feiying Guo, Feiying Guo, Feiying Guo, Huajie Zhong, Huajie Zhong, Yuan Wu, Yuan Wu, Xue Xu, Xue Xu, Jiarong Tan, Qiang Zhou, Shunli Tang, Shunli Tang

    Published 2025-02-01
    “…Dupilumab, a human monoclonal antibody targeting for interleukin (IL)-4/13 receptor α chain, is widely applied in type 2 inflammation diseases treatment. …”
    Get full text
    Article
  6. 6

    Interstitial Granulomatous Drug Reaction to Ustekinumab by A. Walker, J. S. Westerdahl, J. Zussman, J. Mathis

    Published 2022-01-01
    “…Ustekinumab is a human monoclonal antibody that targets inflammatory cytokines IL-12 and IL-23 and has been have shown to be effective in treating IGDR. …”
    Get full text
    Article
  7. 7

    A Case of Childhood Severe Paroxysmal Cold Hemoglobinuria with Acute Renal Failure Successfully Treated with Plasma Exchange and Eculizumab by Jessica Pelletier, Chad Ward, Matthew Borloz, Anne Ickes, Susan Guelich, Erwood Edwards

    Published 2022-01-01
    “…She was successfully treated with plasma exchange and eculizumab, a humanized monoclonal antibody targeting complement protein C5, and demonstrated significant improvement of hemolysis and recovery of renal function.…”
    Get full text
    Article
  8. 8

    Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia by Afdhal Afiq Abd Jalil, Sharifah Faradila Wan Muhamad Hatta, Aimi Fadilah Mohamad, Mohammed Fauzi Abdul Rani

    Published 2021-01-01
    “…Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). …”
    Get full text
    Article
  9. 9

    Evolocumab-induced delayed skin hypersensitivity reaction in a patient with familial hypercholesterolaemia by Grzegorz Porebski, Alicja Dziadowiec

    Published 2024-02-01
    “…In this report, we describe a patient with a delayed cutaneous hypersensitivity reaction to evolocumab, a human monoclonal antibody directed against the serine protease proprotein convertase subtilisin/kexin type 9 used to reduce low-density lipoprotein concentrations in the treatment of familial hypercholesterolaemia. …”
    Get full text
    Article
  10. 10

    Trastuzumab Resistance: Role for Notch Signaling by Kinnari Mehta, Clodia Osipo

    Published 2009-01-01
    “…Trastuzumab, the humanized, monoclonal antibody directed against ErbB-2 has shown tremendous efficacy and improved overall survival for women when combined with a taxane-based chemotherapy. …”
    Get full text
    Article
  11. 11

    Purification and Analysis of the CREPT Antibody from Mouse Ascites by Zhihao Xie, Jun Li, Xinbao Hao, Lu Xu

    Published 2022-01-01
    “…This method is simple to perform and lays a foundation for the preparation and purification of humanized monoclonal antibodies in the future. In addition, it provides a basis for further research to investigate how CREPT affects the occurrence and development of different tumors.…”
    Get full text
    Article
  12. 12

    Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration by Ilias Zampros, Anna Praidou, Periklis Brazitikos, Panagiotis Ekonomidis, Sofia Androudi

    Published 2012-01-01
    “…Pegaptanib sodium, which is an aptamer and ranibizumab, which is a monoclonal antibody fragment. Another humanized monoclonal antibody is currently off-label used, bevacizumab. …”
    Get full text
    Article
  13. 13

    New Possibilities for the Treatment of Crohn’s Disease by Z. A. Mamieva, E. A. Poluektova, O. S. Shifrin

    Published 2019-12-01
    “…Ustekinumab is a fully human monoclonal antibody of the IgG1k class to the p40 subunit of IL-12 and IL-23. …”
    Get full text
    Article
  14. 14

    Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review by Muhammad Husnain, Sandra Kurtin, Nikki Barkett, Irbaz bin Riaz, Amit Agarwal

    Published 2016-01-01
    “…Daratumumab is the first-in-class human monoclonal antibody against CD38 cells which was studied in phase I/II trials for treatment of these patients with relapsed refractory multiple myeloma. …”
    Get full text
    Article
  15. 15

    Respiratory Syncytial Virus Infections in Infants Affected by Primary Immunodeficiency by Marcello Lanari, Silvia Vandini, Maria Grazia Capretti, Tiziana Lazzarotto, Giacomo Faldella

    Published 2014-01-01
    “…Prophylaxis with palivizumab, a humanized monoclonal antibody against the RSV F protein, is currently recommended in high-risk infants born prematurely, with chronic lung disease or congenital heart disease. …”
    Get full text
    Article
  16. 16

    Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms by Joelle El-Amm, Ashley Freeman, Nihar Patel, Jeanny B. Aragon-Ching

    Published 2013-01-01
    “…Another bone-targeted agent is denosumab which is a fully humanized monoclonal antibody that binds to the RANK-L thereby inhibiting RANK-L mediated bone resorption. …”
    Get full text
    Article
  17. 17

    Secukinumab-Induced Inflammatory Bowel Disease in a Patient Treated for Chronic Plaque Psoriasis and Psoriatic Arthritis: A Case Report and Review of the Role of Novel Biologic Age... by K. M. Darch, T. L. Holland, L. J. Spelman

    Published 2020-01-01
    “…Secukinumab (Cosentyx), a fully-human monoclonal antibody that acts by selectively binding to and neutralising the proinflammatory cytokine IL-17A, is used widely for the treatment of both chronic plaque psoriasis and psoriatic arthritis. …”
    Get full text
    Article
  18. 18

    Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective by Nusrat Homaira, William Rawlinson, Thomas L. Snelling, Adam Jaffe

    Published 2014-01-01
    “…Palivizumab, a humanized monoclonal antibody, has been recommended for high risk infants to prevent severe RSV-associated respiratory illness. …”
    Get full text
    Article
  19. 19

    Real-world pharmacovigilance of ofatumumab in multiple sclerosis: a comprehensive FAERS data analysis by Hui Chen

    Published 2025-01-01
    “…BackgroundOfatumumab, a fully human monoclonal antibody targeting CD20, is approved for the treatment of relapsing multiple sclerosis. …”
    Get full text
    Article
  20. 20

    The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system by Yue Zhou, Yutong Wu, Xiao Zhao, Lingxu Xu, Mingguang Sun, Zhaoyou Meng

    Published 2025-01-01
    “…BackgroundOfatumumab is a humanized monoclonal antibody that targets CD20-positive B cells. …”
    Get full text
    Article